George M Ballantyne, MD | |
1755 Highway 34 E, Suite 2200, Newnan, GA 30265-5631 | |
(770) 502-2175 | |
(770) 502-2131 |
Full Name | George M Ballantyne |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 41 Years |
Location | 1755 Highway 34 E, Newnan, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962599936 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 030948 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Piedmont Newnan Hospital, Inc | Newnan, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Georgia Bone And Joint, Llc | 0446291140 | 42 |
News Archive
A new study describes the varying ways in which the virus co-opts the machinery of the host cell following infection to evade or modulate the host immune response, alter the pattern of translation of viral proteins, and the release of new viral particles.
For children with cleft lip and palate, the chances of undergoing secondary surgery vary depending on the center where they're treated, reports a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection met its primary endpoint.
Researchers have identified a self-feeding "vicious circle" of molecules that keeps acute leukemia cells alive and growing and that drives the disease forward.
The health care market is failing to support new antibiotics used to treat some of the world's most dangerous, drug-resistant "superbugs," according to a new analysis by University of Pittsburgh School of Medicine infectious disease scientists.
› Verified 7 days ago
Entity Name | Georgia Bone & Joint, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447276811 PECOS PAC ID: 0446291140 Enrollment ID: O20050512000476 |
News Archive
A new study describes the varying ways in which the virus co-opts the machinery of the host cell following infection to evade or modulate the host immune response, alter the pattern of translation of viral proteins, and the release of new viral particles.
For children with cleft lip and palate, the chances of undergoing secondary surgery vary depending on the center where they're treated, reports a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection met its primary endpoint.
Researchers have identified a self-feeding "vicious circle" of molecules that keeps acute leukemia cells alive and growing and that drives the disease forward.
The health care market is failing to support new antibiotics used to treat some of the world's most dangerous, drug-resistant "superbugs," according to a new analysis by University of Pittsburgh School of Medicine infectious disease scientists.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
George M Ballantyne, MD 1755 Highway 34 E, Suite 2200, Newnan, GA 30265-5631 Ph: (770) 502-2175 | George M Ballantyne, MD 1755 Highway 34 E, Suite 2200, Newnan, GA 30265-5631 Ph: (770) 502-2175 |
News Archive
A new study describes the varying ways in which the virus co-opts the machinery of the host cell following infection to evade or modulate the host immune response, alter the pattern of translation of viral proteins, and the release of new viral particles.
For children with cleft lip and palate, the chances of undergoing secondary surgery vary depending on the center where they're treated, reports a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection met its primary endpoint.
Researchers have identified a self-feeding "vicious circle" of molecules that keeps acute leukemia cells alive and growing and that drives the disease forward.
The health care market is failing to support new antibiotics used to treat some of the world's most dangerous, drug-resistant "superbugs," according to a new analysis by University of Pittsburgh School of Medicine infectious disease scientists.
› Verified 7 days ago
Dr. Domenic Scalamogna, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2201 Newnan Crossing Blvd E Ste 100, Newnan, GA 30265 Phone: 770-460-4747 Fax: 678-673-5102 | |
Dr. David Joseph Love, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1755 Highway 34 E, Newnan, GA 30265 Phone: 770-502-2175 | |
Sunny R Parekh, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1755 Highway 34 E, Newnan, GA 30265 Phone: 804-721-0496 | |
Jayson Alan Mcmath, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1755 Highway 34 E, Suite 2200, Newnan, GA 30265 Phone: 770-502-2175 Fax: 770-502-2131 | |
Virginia M Jones, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2201 Newnan Crossing Blvd E Ste 100, Newnan, GA 30265 Phone: 770-460-4747 Fax: 678-673-5102 | |
Michael V. Cushing, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1755 Highway 34 E, Suite 220, Newnan, GA 30265 Phone: 770-502-2175 Fax: 770-502-2131 | |
Susan Stewart Jordan, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2201 Newnan Crossing Blvd E Ste 100, Newnan, GA 30265 Phone: 770-460-4747 Fax: 678-673-5102 |